Research
Northland Securities Initiates Coverage on Nephros With Market Perform Rating, $4 Price Target
Nephros (NEPH) has an average rating of overweight and mean price target of $6, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
$NEPH
